Grace Durenberger

Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell Carcinoma

Robert L. Diaz, E. Swisher, C. Grandori, 2021, Molecular Cancer Therapeutics.

Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing

Hallie A. Swan, Robert L. Diaz, Shalini C. Pereira, 2023, NPJ precision oncology.

Associations of Multiparametric Breast MRI Features, Tumor-Infiltrating Lymphocytes, and Immune Gene Signature Scores Following a Single Dose of Trastuzumab in HER2-Positive Early-Stage Breast Cancer

Anum S. Kazerouni, S. Partridge, V. Gadi, 2023, Cancers.